Previously, we showed that 11-keto-boswellic acid and 3-Oacetyl-11-keto-BA (AKBA) stimulate Ca 2ϩ mobilization and activate mitogen-activated protein kinases (MAPKs) in human polymorphonuclear leukocytes (PMNLs). Here, we addressed the effects of boswellic acids on the intracellular Ca 
by AKBA was also observed in primary monocytes, isolated from human blood. Moreover, AKBA inhibited the activation of p38 MAPK and ERKs in fMLP-stimulated MM6 cells. Although the effects of AKBA could be mimicked by the putative phospholipase C (PLC) inhibitor U-73122 (1-[6-[[17␤-methoxyestra-1,3 ,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-2,5-dione), AKBA appears to operate independent of PLC activity since the release of intracellular inositol-1,4,5-trisphosphate evoked by 2,4,6-trimethyl-N-(meta-3-trifluoromethyl-phenyl)-benzenesulfonamide was hardly diminished by AKBA. Inhibitor studies indicate that AKBA may decrease [Ca 2ϩ ] i by blocking storeoperated Ca 2ϩ and/or nonselective cation channels. Together, AKBA interferes with pivotal signaling events in monocytic cells that are usually required for monocyte activation by proinflammatory stimuli. Interruption of these events may represent a possible mechanism underlying the reported anti-inflammatory properties of AKBA.
Boswellia serrata gum resin extracts have been traditionally applied in folk medicine for centuries to treat various chronic inflammatory diseases, and experimental data from animal models and clinical studies on humans confirmed an anti-inflammatory potential of B. serrata extracts (for review, see Ammon, 2002) . Detailed analysis of the ingredients of these extracts revealed that the pentacyclic triterpenes boswellic acids (BAs) possess pharmacological activities and may be responsible for the respective anti-inflammatory properties . Approaches to elucidate the cellular and molecular mecha-nisms underlying the clinical effects of BAs identified 5-lipoxygenase (5-LO) (Safayhi et al., 1992) , human leukocyte elastase , topoisomerase I and II (Syrovets et al., 2000) , and IB kinases (Syrovets et al., 2005) as molecular targets. Accordingly, it is speculated that BAs may exert their anti-inflammatory effect mainly by inhibiting the release of proinflammatory leukotrienes from leukocytes (Safayhi et al., 1992) and/or by inhibition of NF-B and subsequent down-regulation of TNF␣ expression in activated monocytes (Syrovets et al., 2005) .
Stimulation of inflammatory cells by an adequate agonist may evoke a number of functional responses including chemotaxis, phagocytosis, degranulation, formation of reactive oxygen species, release of cytokines and chemokines, and liberation of lipid mediators. The transduction and mediation of such agonist-induced responses requires appropriate intracellular signaling systems that operate at multiple levels. Elevation of the intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) is one central signaling event for cell activation (Li et al., 2002) , being involved in the regulation of functional responses such as degranulation or the generation of reactive oxygen species in agonist-challenged leukocytes (Bernardo et al., 1988) . Extracellular stimuli, including the platelet-activating factor (PAF) or N-formyl-methionyl-leucyl-phenylalanine (fMLP), increase the [Ca 2ϩ ] i in monocytes/macrophages, which is composed of a rapid release of Ca 2ϩ from intracellular stores and a Ca 2ϩ influx through plasma membrane Ca 2ϩ channels (Randriamampita and Trautmann, 1989) . Besides Ca 2ϩ , protein phosphorylation is a common signal transduction mechanism integrating extracellular inflammatory signals into leukocyte functions; in particular, MAPK pathways have been shown to play important roles in this respect (Herlaar and Brown, 1999; Johnson and Druey, 2002) . Accordingly, inhibitors of these kinases have been developed to intervene with inflammatory disorders.
We have recently shown that 11-keto-BAs can activate MAPK and induce Ca 2ϩ mobilization in human isolated polymorphonuclear leukocytes (PMNLs) and granulocytic HL-60 cells, which could be linked to various functional responses, including release of arachidonic acid, increased formation of leukotrienes, and generation of reactive oxygen species (Altmann et al., 2002 (Altmann et al., , 2004 
Materials and Methods
Materials. BAs were prepared as described previously (Jauch and Bergmann, 2003) . 2,4,6-Trimethyl-N-(meta-3-trifluoromethyl-phenyl)-benzenesulfonamide (m-3M3FBS) was a generous gift from Dr. T.G. Lee (SIGMOL, Pohang, Korea). U-73122 and SK&F96365 were purchased from Calbiochem (San Diego, CA), Fura-2/AM was from Alexis Corporation (Lä ufelfingen, Switzerland), PAF was from Cayman Chemical (Ann Arbor, MI), 2-aminoethoxydiphenylborate (2-APB) was from Tocris Cookson Inc. (Bristol, UK), and all other chemicals were obtained from Sigma Chemie (Deisenhofen, Germany).
Cells. MM6 cells were maintained in RPMI 1640 medium with glutamine supplemented with 10% fetal calf serum, 100 g/ml streptomycin, 100 U/ml penicillin, 1 mM sodium pyruvate, 1ϫ nonessential amino acids, 1 mM oxalacetic acid, and 10 g/ml bovine insulin. All cultures were seeded at a density of 2 ϫ 10 5 cells/ml. MM6 cells were treated with 2 ng/ml transforming growth factor ␤ and 50 nM calcitriol for 4 days. Cells were harvested by centrifugation (200g, 10 min at room temperature) and washed once in phosphate-buffered saline (PBS), pH 7.4. To exclude toxic effects of BAs during various incubation periods, the viability of MM6 cells was analyzed by trypan blue exclusion. Incubation with 30 M AKBA or 3 M U-73122 at 37°C for up to 30 min caused no significant change in the number of viable cells.
Human PMNLs were freshly isolated from leukocyte concentrates obtained at St. Markus Hospital (Frankfurt, Germany) as described . In brief, venous blood was taken from healthy adult donors, and leukocyte concentrates were prepared by centrifugation at 4000g/20 min/20°C. PMNLs were immediately isolated by dextran sedimentation, centrifugation on Nycoprep cushions (PAA Laboratories GmbH, Linz, Austria), and hypotonic lysis of erythrocytes. Monocytes were obtained from the same leukocyte concentrates after dextran sedimentation and centrifugation on Nycoprep cushions. The mononuclear cells including lymphocytes and monocytes appear as a layer on Nycoprep cushion after centrifugation. The cells were washed twice with PBS, pH 5.9, containing 2 mM EDTA, resuspended in RPMI-1640 supplemented with 2 mM glutamine, 100 g/ml streptomycin, 100 U/ml penicillin, and 20% human plasma, and spread in cell culture flasks at 37°C and 5% CO 2 . After 3 h, lymphocytes in suspension were removed, and adhered monocytes were gently detached and resuspended in PBS plus 1 mg/ml glucose and 1 mM CaCl 2 (PGC buffer).
Measurement of Intracellular Ca 2؉ Levels. MM6 cells or blood monocytes (3 ϫ 10 7 /ml PG buffer) were incubated with 2 M Fura-2/AM for 30 min at 37°C. After washing, 3 ϫ 10 6 cells/ml PG buffer were incubated in a thermally controlled (37°C) fluorometer cuvette in a spectrofluorometer (Aminco-Bowman series 2; Thermo Electron Corporation, Waltham, MA) with continuous stirring. Two min prior to stimulation, 1 mM CaCl 2 or 1 mM EDTA was added. The fluorescence emission at 510 nm was measured after excitation at 340 and 380 nm, respectively, and [Ca 2ϩ ] i was calculated according to Grynkiewicz et al. (1985) . F max (maximal fluorescence) was obtained by lysing the cells with 1% Triton X-100 and F min by chelating Ca 2ϩ with 10 mM EDTA. SDS-Polyacrylamide Gel Electrophoresis and Western Blotting. Prewarmed (37°C) MM6 cells were preincubated with the indicated concentrations of AKBA or vehicle [DMSO, final concentration Յ1% (v/v)] for 5 min prior to stimulation with fMLP (1 M) for 1 min at 37°C. The reaction was stopped by addition of the same volume of ice-cold 2ϫ SDS-polyacrylamide gel electrophoresis (PAGE) sample loading buffer (SDS-b), samples for SDS-PAGE (aliquots corresponding to 2 ϫ 10 6 cells in 20 l SDS-b) were prepared, and proteins were separated as described . Correct loading of the gel and transfer of proteins to the nitrocellulose membrane was confirmed by Ponceau staining. Western blotting using phosphospecific antibodies (1:1000 dilution, each; New England Biolabs, Beverly, MA) against pERK1/2 (Thr202/Tyr204) and pp38 MAPK (Thr180/Tyr182) was performed using a Li-Cor Odyssey two-color Western detection system (Li-Cor, Lincoln, NE) , according to the instructions of the manufacturer. Alternatively, detection of immunoreactive proteins was performed as described previously using alkaline phosphatase-conjugated secondary antibody [20% (v/v) ] and kept on ice for 20 min. Further extraction and evaluation of IP 3 released into the medium was determined using an [ 3 H]IP 3 Biotrak Assay System (GE Healthcare, Little Chalfont, Buckinghamshire, UK) according to the manufacturer's instructions. Data are expressed as percentage of vehicle-treated controls Ϯ S.E., n ϭ 3 to 4. Statistical analysis was performed prior to normalization, p Ͻ 0.05 ‫)ء(‬ or Ͻ0.01 ‫.)ءء(‬ Statistics. Statistical evaluation of the data were performed by one-way analysis of variance for independent or correlated samples followed by Tukey honestly significant difference post hoc tests. Where appropriate, Student's t test for paired observations was applied. p Ͻ 0.05 ‫)ء(‬ or Ͻ0.01 ‫)ءء(‬ was considered significant. 2؉ ] i of Resting MM6 Cells. In our previous reports, we showed that AKBA and KBA, but not A␤BA and ␤BA (lacking the 11-keto group), cause a marked mobilization of Ca 2ϩ in human isolated PMNLs or in the granulocytic cell line HL-60 (Altmann et al., 2002 (Altmann et al., , 2004 ] i were still detectable 20 min after exposure to AKBA (see below). In a previous study using MM6 cells (Feisst and Werz, 2004) , we observed a similar drop of [Ca 2ϩ ] i , when the PLC inhibitor U-73122 (3 M) was added to the cells, which was confirmed in the present experiments (Fig. 1A, (Fig. 1B) . Combined addition of 30 M AKBA plus 3 M U-73122 gave no additive effects versus AKBA or U-73122 alone (data not shown).
Results

AKBA Decreases Basal [Ca
In analogy to PMNLs, the effectiveness of the BAs to affect [Ca 2ϩ ] i in MM6 cells depended on the presence of the 11-keto group and the 3-O-acetyl moiety. Thus, the 11-keto-free counterpart of AKBA, namely A␤BA (30 M), hardly decreased [Ca 2ϩ ] i , and KBA, lacking the 3-O-acetyl moiety, was less efficient than AKBA with respect to this response (Fig. 1 , A and C). Finally, no effect was detectable for ␤BA (30 M).
AKBA (Bae et al., 2003) . The IC 50 value for AKBA was in the range of 10 to 30 M, depending on the stimulus. Representative [Ca 2ϩ ] i traces of PAF-stimulated samples are displayed in Fig. 3B , left panel. In contrast, initial elevation of [Ca 2ϩ ] i induced by the ER/SR-Ca 2ϩ -ATPase inhibitor TG or by the Ca 2ϩ -ionophore ionomycin were not affected (Fig. 3A) . Closer examination revealed that AKBA transforms the sustained elevation of [Ca 2ϩ ] i evoked by TG to a transient signal (Fig.  3B, right panel) .
The amplitudes of the Ca 2ϩ transients of the physiological stimuli PAF and fMLP were still strongly attenuated by AKBA, when the preincubation period was expanded from 20 s to 20 min (Fig. 3C) . In contrast, the suppressive effects of U-73122 were seemingly transient and markedly declined within 20 min for PAF-stimulated cells, but not so for cells challenged with fMLP (Fig. 3C) . Similarly, the decrease in basal [Ca 2ϩ ] i of (unstimulated) MM6 cells after prolonged (20 min) exposure to 30 M AKBA was sustained, whereas for U-73122, the strong initial reduction of basal [Ca 2ϩ ] i detected right after exposure appeared to be transient and again was almost reversed after 20 min (Table 1) (Fig. 4, A and B, left panel) , although slightly higher concentrations of AKBA and U-73122 were required as compared with those needed to suppress total Ca 2ϩ mobilization in the presence of extracellular Ca 2ϩ . Surprisingly, also, Ca 2ϩ mobilization from internal storage sites induced by TG (Fig. 4B, right panel) was partly antagonized by AKBA, implying that PLC inhibition may not be the sole mechanism by which AKBA affects [Ca 2ϩ ] i since TG-mediated Ca 2ϩ mobilization circumvents the PLC/IP 3 route.
AKBA Attenuates fMLP-Evoked MAPK Activation. Cell activation, reflected by elevations in [Ca 2ϩ ] i , is often accompanied by induction of signaling pathways leading to enhanced levels of phosphorylated members of the MAPK family (Belcheva and Coscia, 2002) . The p38 MAPK and ERKs are key effectors in the cellular signaling network of leukocytes. Addition of AKBA to resting MM6 cells caused a reduction of the basal levels of phosphorylated ERK-2, whereas phosphorylation of p38 MAPK was not affected (Fig. 5A) . Note that the phosphorylation state of MAPK solely indicates the activation of the kinases but might not exactly reflect the protein kinase activity toward its substrate(s).
Next, we examined whether AKBA prevents the activation of p38 MAPK and ERKs induced by fMLP that, in contrast to PAF, causes prominent phosphorylation of the MAPK in MM6 cells (D. Poeckel and O. Werz, unpublished data) . Indeed, activation of ERKs was potently prevented by AKBA; again, the amounts of phosphorylated ERK-2 were lower after preincubation with AKBA (10 and 30 M) as compared with vehicle-treated control cells (Fig. 5B) . AKBA also attenuated fMLP-induced phosphorylation of p38 MAPK (Fig. 5B) . It was shown that U-73122 substantially reduces the activation of p38 MAPK in monocytic cells stimulated by lysophosphatidylcholine (Jing et al., 2000) , and we found significant inhibition of fMLP-induced ERK2 activation by U-73122 in MM6 
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Effects of Boswellic Acids on Cellular PLC Activity. To test whether AKBA (in analogy to U-73122) inhibits cellular PLC activity, we assayed the effects of AKBA on the IP 3 formation in intact MM6 cells. Cellular PLC was directly activated using 100 M m-3M3FBS to obtain a prominent increase in IP 3 production (7.9-fold elevation, Fig. 6B ). In agreement with its ability to block total Ca 2ϩ mobilization, U-73122 (5 M) inhibited m-3M3FBS-induced IP 3 formation (ϳ80%, Fig. 6A ). In contrast to its ability to decrease [Ca 2ϩ ] i , AKBA failed to significantly suppress IP 3 formation. Intriguingly, A␤BA, which hardly affected Ca 2ϩ homeostasis, inhibited m-3M3FBS-induced IP 3 generation (ϳ50%, Fig. 6A ).
We then examined whether AKBA, A␤BA, or U-73122 could also affect the basal IP 3 turnover in resting cells. In contrast to m-3M3FBS-activated MM6 cells, no significant stimulatory effect was observed for U-73122 (5 M) or A␤BA. However, AKBA caused a concentration-dependent increase in IP 3 formation as compared with vehicle-treated control (Fig. 7) . To distinguish between NSCC and SOCC, we applied 2-APB (50 M), which blocks SOCCs and, on the other hand, LOE908 (10 M), which selectively inhibits NSCC. Both 2-APB and LOE908 decreased basal [Ca 2ϩ ] i and prevented the effects of AKBA (Fig.  7) . In contrast, inhibitors of voltage-gated Ca 2ϩ channels (300 nM -conotoxin MVIIA or 1 M verapamil, which block L-or N-type channels, respectively), SR-Ca 2ϩ release channels (10 M neomycin), or blockers of the Na ϩ -Ca 2ϩ exchanger (SEA0400 or KB-R7943, 10 M each) failed to significantly decrease basal [Ca 2ϩ ] i and to prevent effects of AKBA (data not shown). Together, these results indicate that AKBA may mediate the decrease of [Ca 2ϩ ] i by blocking Ca 2ϩ influx from the extracellular space via inhibition of SOCC/ NSCC.
Discussion
AKBA and KBA were shown to induce Ca 2ϩ mobilization and activation of MAPK in primary PMNLs and granulocytic HL-60 cells, involving pertussis toxin-sensitive proximal signaling pathways (Altmann et al., 2002 (Altmann et al., , 2004 . Activation of these central signaling events were linked to typical functional responses of granulocytes, including peroxide formation and enhanced metabolism of arachidonic acid; in particular, an increased activity of 5-LO was evident (Altmann et al., 2004) . Such an activation of granulocytes opposes the general observation that extracts of B. serrata or isolated BAs exert anti-inflammatory properties in several cellular experimental settings (Krieglstein et al., 2001; Syrovets et al., 2005) or animal models (Sharma et al., 1989; Gupta et al., 1994) and finally also in studies on human subjects (Gupta et al., 1998; Gerhardt et al., 2001) .
Recently, Syrovets et al. (2005) showed that in activated human monocytes, BAs down-regulate TNF␣ expression via a direct inhibition of IB kinases, providing a molecular basis for the anti-inflammatory properties of BAs. The result from the present investigation focusing on central signaling pathways in monocytes provides additional evidence for an antiinflammatory implication of AKBA at the cellular level. Thus, AKBA decreased the basal [Ca 2ϩ ] i , prevented agonist- . A, prewarmed MM6 cells (2 ϫ 10 6 /100 l PGC buffer) were incubated with the indicated concentrations of AKBA or vehicle (DMSO) for 5 min. B, prewarmed MM6 cells were first incubated with the indicated concentrations of AKBA or vehicle (DMSO) for 15 min prior to stimulation with fMLP (1 M) at 37°C for 1 min. Reactions were terminated by addition of equal volumes of SDS-b. Samples were subjected to SDS-PAGE and Western blotting using phosphospecific antibodies against the dually phosphorylated form of the MAPKs. Samples were concurrently analyzed for p38
MAPK and ERK1/2 activation using the 2-color Western detection system of Li-Cor (Odyssey), hence, loading control (L.C.) bands refer to both antibodies. The results shown are representative of at least three independent experiments. induced Ca 2ϩ mobilization, and blocked the activation of ERK1/2 and p38 MAPK , signaling events that are determinants for typical functional monocyte/macrophage responses (Gijon and Leslie, 1999; Chen et al., 2001) . Interestingly, TNF␣ generation and NF-B activation in monocytic cells may depend on Ca 2ϩ (Pollaud-Cherion et al., 1998; See et al., 2004) , providing a possible link between interference with Ca 2ϩ and down-regulation of NF-B and TNF␣. Apparently, in view of the opposite, agonistic effects on PMNLs and HL-60 cells, AKBA and KBA exert disparate effects on certain cellular processes, depending on the cell type. Thus, in monocytic cells, AKBA may be regarded as pharmacologically active compound that suppresses important signaling events, implying anti-inflammatory functionality. PMNLs that are terminally differentiated are involved in acute inflammatory responses, whereas monocytes act more in chronic inflammation and can undergo differentiation prior to function. Indeed, opposite effects on Ca 2ϩ homeostasis in analogy to AKBA are obvious in leukocytes exposed to arachidonic acid that decreases [Ca 2ϩ ] i in peritoneal macrophages (Randriamampita and Trautmann, 1990) and in MM6 cells (D. Poeckel and O. Werz, unpublished data) but on the other hand evokes Ca 2ϩ mobilization in PMNLs (Naccache et al., 1989) .
Many effector enzymes like phospholipases, 5-LO, and protein kinases respond to and are regulated by an elevation of [Ca 2ϩ ] i , leading to functional monocyte responses including lipid mediator and superoxide release, degranulation, and cytokine generation (Bernardo et al., 1988; Pollaud-Cherion et al., 1998) . Among the four major ␤-configurated BAs present in ethanolic extracts of B. serrata gum, AKBA was most potent, whereas the 11-methylene derivatives were hardly active; also, the absence of the 3-O-acetyl group led to a loss of efficacy. Similarly, for interference with so far all defined molecular pharmacological targets, i.e., 5-LO (Safayhi et al., 1992) , human leukocyte elastase , topoisomerases I and II (Syrovets et al., 2000) , as well as IB kinases (Syrovets et al., 2005) , AKBA possesses the highest potency, being of considerable pharmacological interest (Ammon, 2002) .
The effects of AKBA in MM6 cells showed similar characteristics as the PLC inhibitor U-73122 (Bleasdale et al., 1990) that was found to block acute and chronic inflammatory responses in vivo (Hou et al., 2004) . Indeed, both U-73122 and AKBA rapidly decreased the basal [Ca 2ϩ ] i of resting cells but also caused an immediate drop of the elevated [Ca 2ϩ ] i after challenge with PAF, displaying comparable kinetics. Moreover, both agents reduced agonist-evoked Ca 2ϩ mobilization, which in fact is a characteristic for monocyte activation by external stimuli (Kim et al., 1992; Bernardo et al., 1997; Li et al., 2002) . Such Ca 2ϩ -antagonizing activity of AKBA or U-73122 was evident for agonists (fMLP, PAF, or m-3M3FBS) that act via the PLC/IP 3 pathway. In contrast, initial Ca 2ϩ fluxes induced by the ER/SR-Ca 2ϩ -ATPase inhibitor TG or by the Ca 2ϩ -ionophore ionomycin, which both (Gouy et al., 1990) , were unaffected by either U-73122 or AKBA. Experiments conducted to determine the duration of the Ca 2ϩ suppressing effects, either in resting or in agonist-challenged cells, revealed rather transient efficacy of U-73122, whereas AKBA-mediated antagonism was sustained and long-lasting, implying that the compounds most likely operate through differing mechanisms.
Another common feature of U-73122 and AKBA was their ability to inhibit the PAF-induced release of Ca 2ϩ from internal storage sites. Hence, based on the inhibitory profile and characteristics to affect Ca 2ϩ homeostasis, it first appeared reasonable that the Ca 2ϩ -modulating effects of AKBA could be due to interference with PLC, which is a defined molecular target of U-73122 (Bleasdale et al., 1990) . On the other hand, interference of AKBA with the IP 3 receptor could be a plausible explanation. Surprisingly, however, AKBA significantly inhibited TG-induced Ca 2ϩ mobilization from internal stores and also the sustained elevation of [Ca 2ϩ ] i of TG-treated cells in Ca 2ϩ -containing buffer, suggesting that AKBA may influence Ca 2ϩ homeostasis, at least in part, independent of PLC or IP 3 . An important finding that favors a PLC-independent mechanism is the failure of AKBA to efficiently suppress the release of intracellular IP 3 . Strikingly, in contrast to AKBA, A␤BA clearly failed to counteract m-3M3FBS-induced Ca 2ϩ mobilization, even though it was more efficient than AKBA in inhibiting m-3M3FBS-evoked IP 3 formation. Based on these discrepancies, inhibition of PLC is no satisfying explanation for the potent impairment of [Ca 2ϩ ] i induced by AKBA. This hypothesis is further supported by the fact that AKBA on one hand even slightly increased basal IP 3 levels about 2-fold, which should actually lead to Ca 2ϩ release from internal storage sites. However, in contrast, there is a strong decrease in the basal [Ca 2ϩ ] i under these conditions.
The AKBA-induced loss of intracellular (cytoplasmic) Ca 2ϩ may result from different processes such as extrusion of intracellular Ca 2ϩ to the extracellular space, stimulation of Ca 2ϩ storage (uptake) into intracellular sites (e.g., by activation of a Ca 2ϩ /ATPase), or interference with ion channels allowing Ca 2ϩ influx. Our studies using selective inhibitors of various plasma membrane Ca 2ϩ influx channels imply that AKBA might act (at least in part) by inhibition of SOCC and/or NSCC. Thus, inhibitors of SOCC and/or NSCC mimicked the loss of [Ca 2ϩ ] i observed with AKBA and were able to inhibit the subsequent decrease of [Ca 2ϩ ] i induced by AKBA. Of interest, also for U-73122, inhibition of plasma membrane Ca 2ϩ channels has been accounted for reduced [Ca 2ϩ ] i (see Feisst et al., 2005 , and references therein). In contrast, voltage-gated N-and L-type Ca 2ϩ channels, SRCa 2ϩ release channels (neomycin), or the Na ϩ -Ca 2ϩ exchanger do not seem to mediate the effects of AKBA. It is conceivable that a block of SOCC/NSCC may shift the balance between Ca 2ϩ influx and Ca 2ϩ extrusion toward predominant extrusion that, as a result, leads to impaired [Ca 2ϩ ] i . However, more detailed experiments are required to elucidate the molecular targets and mechanisms underlying the complex regulation of Ca 2ϩ homeostasis by AKBA in MM6 cells, which would go beyond the scope of this study.
Besides antagonizing Ca 2ϩ , AKBA potently prevented fMLP-induced activation of p38 MAPK and ERKs. These MAPK pathways play pivotal roles in the transduction of external mediators to many cellular processes and are strongly implicated in inflammatory disorders (Herlaar and Brown, 1999; Johnson and Druey, 2002) . Among the pharmacological strategies for intervention with inflammation, inhibitors of ERKs may possess potential for the treatment of inflammatory and neuropathic pain (Ji, 2004) . p38 MAPK inhibitors have been developed to treat for example rheumatoid arthritis (Pargellis and Regan, 2003 ) and Crohn's disease (Hommes et al., 2002) , inflammatory disorders that in fact have been successfully treated with B. serrata extracts (Gerhardt et al., 2001) . Of interest, recently also U-73122 was shown to reduce lysophosphatidylcholine-induced p38 MAPK activation in monocytic THP-1 cells (Jing et al., 2000) .
In summary, our data show that AKBA is capable to suppress central signaling events in human monocytic cells, typically important for functional monocyte responses at inflammatory sites. These findings may be added to the list of pharmacological actions of BAs assumed to contribute to the effects of B. serrata extracts observed in animal models and in clinical studies of humans and may be another step forward to the elucidation of the cellular and molecular basis of the anti-inflammatory properties of BAs.
